Identification of microRNAs regulating Hlxb9 gene expression during the induction of insulin‐producing cells
Authors:
- 23 January 2016
- journal article
- research article
- Published by Wiley in Cell Biology International
- Vol. 40 (5) , 515-523
Abstract
Bone marrow mesenchymal stem cells (bMSCs) with the capacity of self‐ renewal and multilineage differentiation are promising sources for cell replacement therapy in diabetes. Here, we developed an effective method with activin A, conophylline, and nicotinamide to induce mouse bMSCs to differentiate into insulin‐producing cells (IPCs). The homeobox gene Hlxb9 (encoding HB9) is prominently expressed in adult human pancreas, which can also play a key role during the induction of IPCs. To find the microRNAs (miRNAs) regulating Hlxb9 gene expression, we respectively used miRanda and TargetScan to predict and got the intersection, miR‐200a and miR‐141, further identified by the Dual‐Luciferase assay. The results illustrated miR‐200a and miR‐141 could inhibit the expression of Hlxb9 by binding to its mRNA 3′UTR. Furthermore, the expression of miR‐200a and miR‐141 was almost reciprocal to that of Hlxb9. Overexpression of miR‐200a and miR‐141 downregulated the expression of pancreatic progenitor cell markers Hlxb9 and Pdx1. Therefore, miR‐200a and miR‐141 may directly or indirectly regulate the expression of pancreatic islet transcription factors to control the differentiation of IPCs.Keywords
Funding Information
- Liaoning Province Education administration funded Program of China (L2013329)
This publication has 20 references indexed in Scilit:
- Towards the elucidation of the regulatory network guiding the insulin producing cells’ differentiationGenomics, 2012
- The widespread regulation of microRNA biogenesis, function and decayNature Reviews Genetics, 2010
- Promotion of β-cell differentiation by the alkaloid conophylline in porcine pancreatic endocrine cellsBiomedicine & Pharmacotherapy, 2010
- Antidiabetic effect of orally administered conophylline-containing plant extract on streptozotocin-treated and Goto-Kakizaki ratsBiomedicine & Pharmacotherapy, 2009
- Administration of Conophylline and Betacellulin-δ4 Increases the β-cell Mass in Neonatal Streptozotocin-treated RatsEndocrine Journal, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Generation of Insulin-Producing Cells from Human Bone Marrow Mesenchymal Stem Cells by Genetic ManipulationStem Cells, 2007
- Conophylline and Betacellulin-.DELTA.4: an Effective Combination of Differentiation Factors for Pancreatic .BETA. CellsEndocrine Journal, 2007
- Chromatin‐Remodeling Factors Allow Differentiation of Bone Marrow Cells into Insulin‐Producing CellsStem Cells, 2006
- Identification of Insulin‐Producing Cells Derived from Embryonic Stem Cells by Zinc‐Chelating DithizoneStem Cells, 2002